Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Swedish startup Cellcolabs has raised $8.7 million to scale industrial stem cell production for healthcare transformation. The company aims to reduce the cost and controversy surrounding stem cells production. This funding will support their efforts in affordable stem cell production.
This Korean startup wants to take on Carta in cap table management: https://t.co/PHHNgFezJv by TechCrunch #infosec #cybersecurity #technology #news
How a new class of climate startups could get a boost from the SEC: https://t.co/oSH4CEWqGG by TechCrunch #infosec #cybersecurity #technology #news
Swedish biotech Cellcolabs secures $8.7M for affordable stem cell production https://t.co/5gHQCmfKfa https://t.co/ykonzuctRC
